← Aurinia Pharmaceuticals Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Profit or Loss | ($23.3m) | ($70.8m) | ($64.1m) | ($123.8m) | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | — | — | — | — | ($102.7m) |
($181.0m)
-76.24%
|
($108.2m)
+40.22%
|
($78.0m)
+27.88%
|
$5.8m
+107.37%
|
$287.2m
+4893.08%
|
— | |
| Depreciation, Depletion and Amortization | — | — | — | — | $82k | $663k | $2.7m | $11.6m | $19.4m | $19.4m | $19.4m | |
| Depreciation | — | — | — | — | $82k | $663k | $629k | $606k | $600k | $600k | $19.4m | |
| Amortization of Intangible Assets | $1.5m | $1.4m | $1.5m | $1.4m | $1.3m | $2.1m | $2.1m | $1.7m | $900k | $800k | — | |
| Amortization Of Securities | — | — | — | — | — | — | ($1.6m) | ($12.1m) | ($12.7m) | ($10.2m) | ($9.2m) | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | $2.7m | $11.6m | $19.4m | $19.4m | $19.4m | |
| Deferred Income Tax Expense (Benefit) | — | — | — | — | $0 | $0 | $0 | $0 | $0 | ($176.2m) | ($155.8m) | |
| Deferred Tax | — | — | — | — | — | — | — | $0 | $0 | ($176.2m) | ($155.8m) | |
| Share-based Payment Arrangement, Noncash Expense | — | — | — | — | $17.5m | $31.2m | $32.3m | $45.3m | $31.6m | $14.7m | $14.6m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | — | $6.1m | $9.8m | — | |
| Adjustments For Share-Based Payments | $1.4m | $4.2m | $6.9m | $7.4m | — | — | — | — | — | — | — | |
| Share-based Payment Arrangement, Expense | — | — | — | — | $17.5m | $31.2m | $32.3m | $45.3m | $31.6m | $14.7m | $14.6m | |
| Asset Impairment Charge | — | — | — | — | — | — | $3.6m | $916k | $0 | $0 | $0 | |
| Changes in operating assets and liabilities: | ||||||||||||
| Change In Working Capital | — | — | — | — | — | — | ($6.8m) | ($5.6m) | $5.4m | ($8.8m) | ($932k) | |
| Change In Receivables | — | — | — | — | — | — | $1.9m | ($10.6m) | ($12.5m) | ($4.9m) | ($1.0m) | |
| Changes In Account Receivables | — | — | — | — | — | — | $1.9m | ($10.6m) | ($12.5m) | ($4.9m) | ($1.0m) | |
| Increase (Decrease) in Inventories | — | — | — | — | $13.9m | $5.6m | $9.1m | $15.9m | ($477k) | $6.5m | $1.4m | |
| Inventory Write-down | — | — | — | — | — | — | $3.6m | $916k | $0 | $0 | — | |
| Change In Inventory | — | — | — | — | — | — | ($9.1m) | ($15.9m) | $477k | ($6.5m) | $1.4m | |
| Increase (Decrease) in Accounts Payable | — | — | — | — | — | — | — | — | $860k | ($1.9m) | ($3.5m) | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | $699k | $13.4m | $14.2m | ($6.5m) | ($3.5m) | |
| Change In Accrued Expense | — | — | — | — | — | — | $1.5m | $12.2m | $13.3m | ($4.7m) | $7.5m | |
| Change In Other Current Assets | — | — | — | — | — | — | ($363k) | ($16k) | $31k | $730k | $0 | |
| Change In Other Current Liabilities | — | — | — | — | — | — | ($652k) | ($673k) | ($750k) | ($802k) | ($848k) | |
| Other Operating Income (Expense), Net | — | — | — | — | $6.8m | ($574k) | $1.5m | ($8.4m) | $4.3m | ($9.5m) | — | |
| Net Cash Provided by (Used in) Operating Activities | ($18.7m) |
($41.2m)
-120.00%
|
($51.6m)
-25.36%
|
($63.5m)
-22.95%
|
($69.9m)
-10.09%
|
($157.7m)
-125.73%
|
($79.5m)
+49.57%
|
($33.5m)
+57.93%
|
$44.4m
+232.66%
|
$135.7m
+205.62%
|
$175.2m
+29.18%
|
|
| Cash flows from investing activities: | ||||||||||||
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $19k | $0 | $20k | $159k | — | — | — | — | — | — | — | |
| Capital Expenditure | — | — | — | — | — | — | ($292k) | ($718k) | ($281k) | ($252k) | ($176k) | |
| Capital Expenditure Reported | — | — | — | — | — | ($6k) | $0 | — | — | — | ($176k) | |
| Net Other Investing Changes | — | — | — | — | — | ($17.8m) | ($663k) | ($11.9m) | ($43k) | — | ($43k) | |
| Net Cash Provided by (Used in) Investing Activities | $10.0m | ($8.0m) | ($66k) | $7.8m | ($158.2m) | ($103.9m) | ($60.6m) | ($6.7m) | $39.3m | ($32.8m) | $12.8m | |
| Cash flows from financing activities: | ||||||||||||
| Long Term Debt Payments | — | — | — | — | — | — | $0 | ($10.0m) | ($12.0m) | ($13.1m) | ($14.0m) | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $0 | ($10.0m) | ($12.0m) | ($13.1m) | ($14.0m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $0 | ($10.0m) | ($12.0m) | ($13.1m) | ($14.0m) | |
| Repayment Of Debt | — | — | — | — | — | — | $0 | ($10.0m) | ($12.0m) | ($13.1m) | ($14.0m) | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | — | — | — | $40.2m | $98.2m | — | |
| Proceeds from Issuance of Common Stock | — | — | — | — | $187.7m | $196.7m | $0 | $0 | $1.1m | $756k | $0 | |
| Common Stock Issuance | — | — | — | — | — | $196.7m | $0 | $0 | ($40.2m) | ($98.2m) | $0 | |
| Common Stock Payments | — | — | — | — | — | — | $0 | $0 | ($40.2m) | ($98.2m) | ($83.6m) | |
| Issuance Of Capital Stock | — | — | — | — | — | $196.7m | $0 | $0 | — | — | $0 | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | $0 | $0 | ($40.2m) | ($98.2m) | ($83.6m) | |
| Net Other Financing Charges | — | — | — | — | — | — | ($1.0m) | ($2.3m) | ($6.1m) | ($9.8m) | ($27.2m) | |
| Net Cash Provided by (Used in) Financing Activities | $42.6m |
$175.2m
+311.01%
|
$4.0m
-97.71%
|
$243.7m
+5971.95%
|
$194.4m
-20.25%
|
$221.1m
+13.76%
|
$2.4m
-98.90%
|
($5.1m)
-310.85%
|
($49.1m)
-856.96%
|
($106.1m)
-116.15%
|
($61.3m)
+42.27%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $33.9m | $126.0m | ($47.7m) | $188.1m | ($33.7m) | ($40.5m) | ($137.7m) | ($45.3m) | $34.6m | ($3.2m) | $179.8m | |
| Beginning Cash Position | — | — | — | — | — | — | $231.9m | $94.2m | $48.9m | $83.4m | $53.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | $272.4m | $231.9m | $94.2m | $48.9m | $83.4m | $80.2m | $179.8m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $107k | $3.9m | $943k | $13.7m | $6.6m | $24.0m | $2.4m | $4.9m | $8.2m | $14.2m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, Net | — | — | — | — | — | — | $2.0m | $496k | $2.2m | $2.8m | — | |
| Additional Financial Items | ||||||||||||
| Adjustments For Decrease Increase In Trade Account Receivable | ($39k) | ($23k) | ($108k) | ($151k) | — | — | — | — | — | — | — | |
| Adjustments For Increase Decrease In Trade Account Payable | $2.5m | $2.2m | ($888k) | $4.1m | — | — | — | — | — | — | — | |
| General and Administrative Expense | $7.0m | $12.1m | $13.7m | $22.2m | $96.0m | $171.4m | $196.4m | $195.0m | $172.0m | $101.8m | — | |
| Income Tax Expense (Benefit) | — | — | — | — | ($94k) | $760k | $1.8m | $551k | $1.7m | ($173.0m) | — | |
| Increase Decrease In Working Capital | ($1.5m) | ($1.7m) | $6.0m | ($2.1m) | — | — | — | — | — | — | ($932k) | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $4.8m | $4.3m | — | |
| Interest Received Classified As Operating Activities | $34k | $973k | $2.1m | $2.6m | — | — | — | — | — | — | — | |
| Investment Income, Interest | — | — | — | — | — | — | — | — | $17.0m | $13.6m | — | |
| Operating Expenses | — | — | — | — | $154.4m | — | — | — | $239.8m | $178.1m | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | ($127k) | — | — | — | — | — | — | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | $10k | $0 | $45k | $17k | — | — | — | — | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | — | — | $23.1m | $1.6m | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $2.4m | ($5.1m) | ($49.1m) | ($106.1m) | ($61.3m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($60.6m) | ($6.7m) | $39.3m | ($32.8m) | $12.8m | |
| Change In Account Payable | — | — | — | — | — | — | ($792k) | $1.2m | $860k | ($1.9m) | ($3.5m) | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | ($137.7m) | ($45.3m) | $34.6m | ($3.2m) | — | |
| Change In Other Working Capital | — | — | — | — | — | — | $3.0m | $3.8m | $5.8m | $3.7m | $226k | |
| Change In Payable | — | — | — | — | — | — | ($792k) | $1.2m | $860k | ($1.9m) | ($3.5m) | |
| Change In Prepaid Assets | — | — | — | — | — | — | ($2.4m) | $4.4m | ($1.8m) | $5.5m | ($4.6m) | |
| Changes In Cash | — | — | — | — | — | — | ($137.7m) | ($45.3m) | $34.6m | ($3.2m) | $126.8m | |
| End Cash Position | — | — | — | — | — | — | $94.2m | $48.9m | $83.4m | $80.2m | $179.8m | |
| Financing Cash Flow | — | — | — | — | — | — | $2.4m |
($5.1m)
-310.85%
|
($49.1m)
-856.96%
|
($106.1m)
-116.15%
|
($61.3m)
+42.27%
|
|
| Free Cash Flow | — | — | — | — | — | — | ($79.8m) | ($34.2m) | $44.1m | $135.4m | $175.1m | |
| Interest Paid Supplemental Data | — | — | — | — | — | $257k | $2.0m | — | — | — | — | |
| Investing Cash Flow | — | — | — | — | — | — | ($60.6m) | ($6.7m) | $39.3m | ($32.8m) | $12.8m | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | — | — | $0 | $5.9m | ($5.9m) | $9.7m | ($557k) | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | ($1.2m) | $0 | $0 | — | — | — | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($59.7m) | $5.9m | $39.6m | ($32.5m) | $7.8m | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | ($292k) | ($718k) | ($281k) | ($252k) | ($176k) | |
| Operating Gains Losses | — | — | — | — | — | — | — | $5.9m | ($5.9m) | $9.7m | ($557k) | |
| Other Non Cash Items | — | — | — | — | — | — | ($1.6m) | ($1.5m) | $788k | ($200k) | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $3.5m | $7.2m | $9.3m | $14.9m | $63.5m | |
| Purchase Of Intangibles | — | — | — | — | — | ($1.2m) | $0 | $0 | — | — | — | |
| Purchase Of Investment | — | — | — | — | — | — | ($524.0m) | ($523.5m) | ($545.8m) | ($526.6m) | ($440.0m) | |
| Purchase Of PPE | — | $25k | $30k | $87k | — | — | ($292k) | ($718k) | ($281k) | ($252k) | ($176k) | |
| Sale Of Investment | — | — | — | — | — | — | $464.3m | $529.4m | $585.4m | $494.1m | $447.8m | |
| Stock Based Compensation | — | — | — | — | — | — | $32.3m | $45.3m | $31.6m | $14.7m | $14.6m |